Prescription Required.Why?
Type 2 diabetes mellitus
To improve glycemic control (blood sugar levels) in adults with type 2 diabetes
Dapagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor. It works by blocking the reabsorption of glucose in the kidneys, leading to increased glucose excretion in the urine. Vildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. It works by increasing the levels of incretin hormones, which stimulate insulin secretion from the pancreas and suppress glucagon secretion, ultimately lowering blood sugar levels.
Store at room temperature, away from direct sunlight and moisture. Keep out of reach of children.
The recommended starting dose is one tablet taken once daily, with or without food.
The dose may be adjusted based on individual response and blood sugar levels.
Do not crush or chew the tablets.
Take the medication as prescribed by your doctor.
Urinary tract infections
Yeast infections (vaginal or penile)
Increased urination
Dehydration
Low blood sugar (hypoglycemia)
Nausea
Vomiting
Diarrhea
Constipation
Headache
Fatigue
Alcohol consumption may increase the risk of hypoglycemia. It is advisable to limit alcohol intake.
Dapagliflozin + Vildagliptin may cause dizziness, especially during the initial stages of treatment. Avoid driving or operating machinery if you experience dizziness.
This medication is not recommended during pregnancy and breastfeeding. Consult your doctor if you are pregnant, planning to become pregnant, or breastfeeding.
This medication is not approved for use in children.
Kidney problems may increase the risk of side effects. Your doctor may need to adjust the dosage or monitor you closely.
Liver problems may affect how this medication is processed in your body. Consult your doctor if you have liver problems.
The information provided is intended for general knowledge and informational purposes only, and does not constitute medical advice. Always consult with a qualified healthcare professional before making any decisions related to your health or treatment.
Please refer to the patient information leaflet or consult with your doctor, pharmacist, or other healthcare provider for complete and up-to-date information on this medication.
